---
schema_version: "secwatch.filing_event.v1"
accession: "0001411690-25-000008"
form_type: "8-K"
ticker: "BNGO"
cik: "0001411690"
company_name: "Bionano Genomics, Inc."
filed_at: "2025-01-27T23:59:59+00:00"
generated_at: "2026-05-27T09:09:12.560667+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Bionano Genomics effects 1-for-60 reverse stock split effective Jan 24, 2025

## Summary
- Reverse stock split at ratio 1:60, effective 5:00 p.m. ET on January 24, 2025.
- Common stock begins trading split-adjusted on Nasdaq Capital Market under BNGO on Jan 27.
- No fractional shares issued; stockholders entitled to fractional shares receive cash in lieu.
- Proportionate adjustments to stock options, RSUs, warrants, and convertible debentures exercise prices and share counts.
- New CUSIP number for common stock post-split: 09075F404.

## SEC filing metadata
- accession: 0001411690-25-000008
- form_type: 8-K
- ticker: BNGO
- cik: 0001411690
- company_name: Bionano Genomics, Inc.
- filed_at: 2025-01-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.03, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411690/000141169025000008/0001411690-25-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411690/000141169025000008/bngo-20250124.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001411690-25-000008
- JSON: https://secwatch.observer/filing/0001411690-25-000008.json
- Plain text: https://secwatch.observer/filing/0001411690-25-000008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.